[S,S]-Reboxetine Dose-Range Finding Trial
Public ClinicalTrials.gov record NCT00288652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
[S,S]-Reboxetine Dose-Range Finding Trial: A 16-Week, Randomized, Double-Blind, Placebo And An Active Comparator Controlled, Multi-Center Trial Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effectiveness of different doses of \[S,S\]-Reboxetine in the treatment of chronic pain following a shingles infection
Study identification
- NCT ID
- NCT00288652
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 280 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Feb 2007 (Actual)
- Last update posted
- Jun 8, 2011
2006 – 2007
United States locations
- U.S. sites
- 79
- U.S. states
- 28
- U.S. cities
- 79
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Huntsville | Alabama | — | — |
| Pfizer Investigational Site | Chandler | Arizona | — | — |
| Pfizer Investigational Site | Mesa | Arizona | — | — |
| Pfizer Investigational Site | Phoenix | Arizona | — | — |
| Pfizer Investigational Site | Sun City | Arizona | — | — |
| Pfizer Investigational Site | Tucson | Arizona | — | — |
| Pfizer Investigational Site | Hot Springs | Arkansas | — | — |
| Pfizer Investigational Site | Arcadia | California | — | — |
| Pfizer Investigational Site | Fullerton | California | — | — |
| Pfizer Investigational Site | Irvine | California | — | — |
| Pfizer Investigational Site | Laguna Hills | California | — | — |
| Pfizer Investigational Site | Loma Linda | California | — | — |
| Pfizer Investigational Site | Orange | California | — | — |
| Pfizer Investigational Site | Redondo Beach | California | — | — |
| Pfizer Investigational Site | Whittier | California | — | — |
| Pfizer Investigational Site | Boulder | Colorado | — | — |
| Pfizer Investigational Site | Bradenton | Florida | — | — |
| Pfizer Investigational Site | Clearwater | Florida | — | — |
| Pfizer Investigational Site | Fort Myers | Florida | — | — |
| Pfizer Investigational Site | Holly Hill | Florida | — | — |
| Pfizer Investigational Site | Hollywood | Florida | — | — |
| Pfizer Investigational Site | Kissimmee | Florida | — | — |
| Pfizer Investigational Site | Largo | Florida | — | — |
| Pfizer Investigational Site | Longwood | Florida | — | — |
| Pfizer Investigational Site | Melbourne | Florida | — | — |
| Pfizer Investigational Site | Ocala | Florida | — | — |
| Pfizer Investigational Site | Oviedo | Florida | — | — |
| Pfizer Investigational Site | Palm Beach Gardens | Florida | — | — |
| Pfizer Investigational Site | Plantation | Florida | — | — |
| Pfizer Investigational Site | Chicago | Illinois | — | — |
| Pfizer Investigational Site | Oak Brook | Illinois | — | — |
| Pfizer Investigational Site | Evansville | Indiana | — | — |
| Pfizer Investigational Site | Topeka | Kansas | — | — |
| Pfizer Investigational Site | Ruston | Louisiana | — | — |
| Pfizer Investigational Site | Towson | Maryland | — | — |
| Pfizer Investigational Site | Boston | Massachusetts | — | — |
| Pfizer Investigational Site | Brockton | Massachusetts | — | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | — | — |
| Pfizer Investigational Site | Southaven | Mississippi | — | — |
| Pfizer Investigational Site | Independence | Missouri | — | — |
| Pfizer Investigational Site | Kansas City | Missouri | — | — |
| Pfizer Investigational Site | Nixa | Missouri | — | — |
| Pfizer Investigational Site | Sprinfield | Missouri | — | — |
| Pfizer Investigational Site | St Louis | Missouri | — | — |
| Pfizer Investigational Site | Billings | Montana | — | — |
| Pfizer Investigational Site | Clifton | New Jersey | — | — |
| Pfizer Investigational Site | Hackensack | New Jersey | — | — |
| Pfizer Investigational Site | Teaneck | New Jersey | — | — |
| Pfizer Investigational Site | Sante Fe | New Mexico | — | — |
| Pfizer Investigational Site | Albany | New York | — | — |
| Pfizer Investigational Site | Amherst | New York | — | — |
| Pfizer Investigational Site | New York | New York | — | — |
| Pfizer Investigational Site | Orchard Park | New York | — | — |
| Pfizer Investigational Site | Rochester | New York | — | — |
| Pfizer Investigational Site | Asheville | North Carolina | — | — |
| Pfizer Investigational Site | Raleigh | North Carolina | — | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | — | — |
| Pfizer Investigational Site | Fargo | North Dakota | — | — |
| Pfizer Investigational Site | Canfield | Ohio | — | — |
| Pfizer Investigational Site | Cincinnati | Ohio | — | — |
| Pfizer Investigational Site | Cleveland | Ohio | — | — |
| Pfizer Investigational Site | Columbus | Ohio | — | — |
| Pfizer Investigational Site | Kettering | Ohio | — | — |
| Pfizer Investigational Site | Toledo | Ohio | — | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | — | — |
| Pfizer Investigational Site | Allentown | Pennsylvania | — | — |
| Pfizer Investigational Site | Altoona | Pennsylvania | — | — |
| Pfizer Investigational Site | Duncansville | Pennsylvania | — | — |
| Pfizer Investigational Site | Jackson | Tennessee | — | — |
| Pfizer Investigational Site | Kingsport | Tennessee | — | — |
| Pfizer Investigational Site | Austin | Texas | — | — |
| Pfizer Investigational Site | Dallas | Texas | — | — |
| Pfizer Investigational Site | Houston | Texas | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Norfolk | Virginia | — | — |
| Pfizer Investigational Site | Richmond | Virginia | — | — |
| Pfizer Investigational Site | Seattle | Washington | — | — |
| Pfizer Investigational Site | Spokane | Washington | — | — |
| Pfizer Investigational Site | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00288652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2011 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00288652 live on ClinicalTrials.gov.